联系人：孙先生
邮箱：yuannsw@aliyun.com
电话：021-59990361
传真：021-59990361
手机：15162680674
手机：15901919684
QQ：1030596099
地址：上海嘉定区安亭镇墨玉路60弄
邮 编：201805
Http：//www.yuannsw.com
| Abacavir Sulfate (200 mg) | R028L0 | F1L487 (31-DEC-2016) | 188062-50-2 |
| Abacavir Sulfate Racemic (20 mg) (4-[2-amino-6-(cyclopropylamino)-9H-purin-9yl]-2-cyclopentene-1-methanol sulfate (2:1)) | F0G248 | 188062-50-2 | |
| Abacavir Related Compound A (20 mg) ([4-(2,6-diamino-9H-purin-9-yl)cyclopent-2-enyl]methanol) | F1L311 | F0H284 (31-OCT-2013) | 124752-25-6 |
| Abacavir Related Compound D (20 mg) (N6-Cyclopropyl-9-{(1R,4S)-4-[(2,5-diamino-6-chlorpyrimidin-4-yloxy)methyl] cyclopent-2-enyl}-9H-purine-2,6-diamine) | F0M143 | N/A | |
| Abacavir Related Compound B (20 mg) ([4-(2,5-diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol) | F1L318 | F0H283 (31-OCT-2013) | N/A |
| Abacavir Related Compound C (20 mg) ([(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-enyl]methanol hydrochloride) | F1L322 | F0H285 (30-SEP-2013) | 172015-79-1 |
| Abacavir Related Compounds Mixture (15 mg) | R039P0 | F0J094 (30-NOV-2016) | N/A |
| Abacavir Stereoisomers Mixture (15 mg) | R044D0 | F0J102 (28-FEB-2017) | N/A |
| Abacavir System Suitability Mixture (15 mg) | F0J097 | N/A | |
| Acarbose (200 mg) (COLD SHIPMENT REQUIRED) | F0M160 | 56180-94-0 | |
| Acarbose System Suitability Mixture (2 mg) (COLD SHIPMENT REQUIRED) | F0L204 | N/A | |
| Acamprosate Calcium (200 mg) | F0M484 | 77337-73-6 | |
| Acamprosate Related Compound A (15 mg) (3-aminopropane-1-sulfonic acid) | F0M499 | 3687-18-1 | |
| Acebutolol Hydrochloride (125 mg) | F005N2 | F-1 (31-JUL-2015) | 34381-68-5 |
| Acebutolol Related Compound A (20 mg) (N-(3-acetyl-4-hydroxyphenyl) butanamide) | F1G041 | F0G041 (31-JUL-2015) | 40188-45-2 |
| Acebutolol Related Compound B (20 mg) (N-{3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl}acetamide) | F005G0 | 22568-64-5 | |
| Acebutolol Related Compound I (20 mg) (N-{3-Acetyl-4-[3-(ethylamino)-2-hydroxypropoxy]phenyl}butyramide) | F005H0 | 441019-91-6 | |
| Abiraterone Acetate (200 mg) | F029L0 | 154229-18-2 | |
| Abiraterone System Suitability Mixture (20 mg) | F01710 | N/A | |
| Acenocoumarol (200 mg) | G0D300 | F (31-OCT-2005) | 152-72-7 |
| Acepromazine Maleate (250 mg) | R003N0 | F-2 (31-OCT-2015) | 3598-37-6 |
| Acesulfame Potassium (200 mg) | G0H082 | F0C136 (30-JUN-2009) | 55589-62-3 |
| Acetaminophen (400 mg) | K0I244 | J2C423 (31-JUL-2011) | 103-90-2 |
| Acetaminophen Related Compound A (15 mg) (4-(acetylamino)phenyl acetate) | F0J252 | 2623-33-8 | |
| Acetaminophen Related Compound B (30 mg) (N-(4-hydroxyphenyl)propanamide) | R012P0 | F1M245 (31-AUG-2015) | 1693-37-4 |
| Acetaminophen Related Compound C (50 mg) (N-(2-hydroxyphenyl)acetamide) | R00920 | F1M247 (31-AUG-2015) | 614-80-2 |
| Acetaminophen Related Compound D (50 mg) (N-phenylacetamide) | R01300 | F0L221 (30-SEP-2016) | 103-84-4 |
| Acetaminophen Related Compound F (50 mg) (p-nitrophenol) | F0M236 | 100-02-7 | |
| Acetaminophen Related Compound J (50 mg) (N-(4-chlorophenyl)acetamide) | R00310 | F0L222 (31-JUL-2015) | 539-03-7 |
| Acetanilide Melting Point Standard (1g) (Approximately 114 degrees) | M1M285 | M0A029 (30-SEP-2014) | 103-84-4 |
| Acetazolamide (2 g) | K0J032 | J1E041 (31-JAN-2011) | 59-66-5 |
| Acetazolamide Related Compound D (25 mg) (5-Amino-1,3,4-thiadiazole-2-sulfonamide) | F025E0 | 14949-00-9 | |
| Acetazolamide Related Compound E (25 mg) (5-Acetamido-1,3,4-thiadiazole-2-sulfonic acid potassium salt) | F025H0 | N/A | |
| Glacial Acetic Acid (1.5 mL/ampule; 3 ampules) | I0M342 | H0K218 (30-NOV-2015) | 64-19-7 |
| Acetohexamide (250 mg) | H | G-1 (30-JUN-1999) | 968-81-0 |
| Acetohydroxamic Acid (200 mg) | F-1 | F (31-MAR-2003) | 546-88-3 |
| Acetone (1.5 mL/ampule; 3 ampules) | I0M548 | H0K208 (31-MAR-2017) | 67-64-1 |
| Propoxyphene Related Compound B (50 mg) (alpha-d-2-Acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane) | I0I291 | H0D012 (30-NOV-2011) | 53990-51-5 |
| Acetylcholine Chloride (200 mg) | R023K0 | H0F091 (30-SEP-2015) | 60-31-1 |
| Acetylcysteine (200 mg) | K0K294 | J0I282 (30-NOV-2012) | 616-91-1 |
| 2-Acetylpyridine (1 g) | F0K307 | 1122-62-9 | |
| Acetyltributyl Citrate (500 mg) | H0I337 | G0C120 (31-DEC-2011) | 77-90-7 |
| Acetyltriethyl Citrate (500 mg) | R041M0 | H0I339 (31-JAN-2017) | 77-89-4 |
| N-Acetyl-D,L-Methionine (100 mg) | F03580 | 1115-47-5 | |
| N-Acetylglucosamine (200 mg) | F0L512 | 7512-17-6 | |
| N-Acetyl-L-Tyrosine (100 mg) | F0I085 | 537-55-3 | |
| Acetyl Simvastatin (30 mg) ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acetoxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate) | F00660 | 145576-25-6 | |
| Acitretin (200 mg) | R04460 | F0E266 (31-JAN-2017) | 55079-83-9 |
| Acitretin Related Compound A (20 mg) ((2Z,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid) | F0E264 | 69427-46-9 | |
| Acitretin Related Compound B (20 mg) (ethyl (all-E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate) | F0E265 | 54350-48-0 | |
| Adapalene (200 mg) | R03020 | F0L117 (31-JUL-2016) | 106685-40-9 |
| Adapalene Related Compound A (50 mg) (Methyl 6-bromo-2-naphthoate) | F0K418 | 33626-98-1 | |
| Adapalene Related Compound B (50 mg) (Methyl 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoate) | F0K419 | 106685-41-0 | |
| Adapalene Related Compound C (25 mg) (2-(adamant-1-yl)methoxybenzene) | F0L078 | 43109-77-9 | |
| Adapalene Related Compound D (25 mg) (4,4'-dimethoxy-3,3'-di(adamant-1-yl)biphenyl) | F0L079 | 932033-57-3 | |
| Adapalene Related Compound E (25 mg) (2,2'-binaphthyl-6,6'-dicarboxylic acid) | F0L080 | 932033-58-4 | |
| Adrenalone Hydrochloride (25 mg) (3',4'-Dihydroxy-2-(methylamino)acetophenone hydrochloride) | F032A0 | 62-13-5 | |
| Actein (20 mg) | F0H264 | 18642-44-9 | |
| Acyclovir Related Compound F (50 mg) (N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide) | F1M502 | F0L515 (29-FEB-2016) | 110104-37-5 |
| Acyclovir (300 mg) | K0L516 | J1G366 (31-MAY-2015) | 59277-89-3 |
| Acyclovir Related Compound A (50 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate) | R023H0 | I0M125 (31-JUL-2016) | 102728-64-3 |
| Acyclovir Related Compound G (50 mg) (2-{[2-(Acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy}ethyl acetate) | F0L510 | 75128-73-3 | |
| Adenine (200 mg) | I0M090 | H0I348 (31-MAY-2014) | 73-24-5 |
| S-Adenosyl-L-Homocysteine (50 mg) | R02130 | F0G241 (30-SEP-2016) | 979-92-0 |
| Adenosine (200 mg) | I0M365 | H0J390 (31-JUL-2015) | 58-61-7 |
| Ademetionine Disulfate Tosylate (500 mg) (S-Adenosyl-L-Methionine Disulfate Tosylate) | F0D073 | 97540-22-2 | |
| Agigenin (25 mg) | F | 55332-76-8 | |
| Aflatoxins (1 mL) (International Restricted Sales Item)(COLD SHIPMENT REQUIRED) | F0K319 | N/A | |
| 5'-Adenylic Acid (500 mg) | F0J204 | 61-19-8 | |
| Adipic Acid (100 mg) | F0D318 | 124-04-9 | |
| Agnuside (25 mg) | F0D397 | 11027-63-7 | |
| Agar (500 mg) | F0K137 | N/A | |
| Beta Alanine (100 mg) | R033Y0 | F0F111 (31-AUG-2016) | 107-95-9 |
| L-Alanine (200 mg) | H0M400 | G1J091 (31-DEC-2014) | 56-41-7 |
| L-Alanyl-L-Glutamine (200 mg) | F004H0 | 39537-23-0 | |
| L-Alanyl-L-Alanine (200 mg) | F0M225 | 1948-31-8 | |
| Albendazole (200 mg) | R02690 | H1K275 (30-NOV-2015) | 54965-21-8 |
| rAlbumin Human (6 mg) (Recombinant Human Albumin) (COLD SHIPMENT REQUIRED) | R04600 | G0M268 (31-DEC-2016) | N/A |
| Albuterol (200 mg) | I | H (31-DEC-2000) | 18559-94-9 |
| Albuterol Sulfate (200 mg) | K0G284 | J (28-FEB-2009) | 51022-70-9 |
| Albuterol Related Compound A (25 mg) (4-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2-methylphenol sulfate) | F0H223 | 18910-68-4 | |
| Albuterol Related Compound B (10 mg) (2-(tert-butylamino)-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone) | F0M123 | 156547-62-5 | |
| Alcohol Determination--Alcohol (5 mL/ampule; 5 ampules) | G0M024 | F0C399 (31-MAY-2015) | 64-17-5 |
| Albuterol Related Compound E (10 mg) (2,2'-oxybis(methylene)bis{4-[2-(tert-butylamino)-1-hydroxyethyl]phenol} diacetate) | F0M127 | N/A | |
| Alcohol Determination--Acetonitrile | F0C419 | N/A | |
| Alclometasone Dipropionate Related Compound A (20 mg) (11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate) | F0K017 | N/A | |
| Alclometasone Dipropionate (300 mg) | I0C302 | H (30-SEP-2007) | 66734-13-2 |
| Alcohol (1.2 mL/ampule; 5 ampules) | G0L460 | F0D030 (30-NOV-2014) | 64-17-5 |
| Dehydrated Alcohol (1.2 mL/ampule; 5 ampules) | G0M292 | F0D031 (31-JUL-2015) | 64-17-5 |
| Alendronate Sodium (200 mg) | H0H004 | G0D288 (31-AUG-2009) | 121268-17-5 |
| Aleuritic Acid (50 mg) | F02300 | 533-87-9 | |
| Alitame (250 mg) | F0J259 | 99016-42-9 (hydrate); 80863-62 | |
| Alitame - Alanine Amide Impurity (25 mg) (N-(2,2,4,4-tetramethyl-3-thietanyl)-D-alanimamide) | F0M119 | 80875-07-6 | |
| Alfuzosin System Suitability Mixture A (25 mg) (Alfuzosin Hydrochloride containing Impurity A, Impurity D, and Impurity E) | F0L107 | N/A | |
| Alfentanil Hydrochloride CII (500 mg) | G1J037 | G0J037 (31-MAR-2016) | 70879-28-6 |
| Alfuzosin Hydrochloride (150 mg) | F0H162 | 81403-68-1 | |
| Alfuzosin System Suitability Mixture (15 mg) | F0H067 | N/A | |
| Allantoin (200 mg) | G1H207 | G0H207 (29-FEB-2016) | 97-59-6 |
| Alliin (25 mg) | F2L004 | F1L004 (30-NOV-2016) | 556-27-4 |
| Allopurinol (250 mg) | J0C186 | I-1 (31-JAN-2005) | 315-30-0 |
| Allopurinol Related Compound B (25 mg) (5-(formylamino)-1H-pyrazole-4-carboxamide) | R02700 | G0J139 (30-SEP-2016) | 22407-20-1 |
| Allopurinol Related Compound A (25 mg) (3-Amino-4-carboxamidopyrazole Hemisulfate) | I0M517 | H0K282 (31-MAY-2015) | 27511-79-1 |
| Allopurinol Related Compound C (25 mg) (5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide) | R00780 | G0J066 (30-APR-2015) | N/A |
| Allopurinol Related Compound D (35 mg) (ethyl 5-amino-1H-pyrazole-4-carboxylate) | F0G085 | 6994-25-8 | |
| S-Allyl-L-cysteine (25 mg) | F | N/A | |
| Allopurinol Related Compound E (25 mg) (ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate) | R014H0 | G0M120 (30-SEP-2015) | 31055-19-3 |
| Allopurinol Related Compound F (25 mg) (ethyl-(E/Z)-3-(2-carbethoxy-2-cyanoethenyl)amino-1H-pyrazole-4-carboxylate) | R028V0 | G0J148 (30-NOV-2014) | 321571-07-7 |
| Almond Oil (1 g) | F0L399 | 8007-69-0 | |
| Almotriptan Malate (200 mg) | F0J054 | 181183-52-8 | |
| Almotriptan Related Compound A (20 mg) ({3-[2-(Dimethylamino)ethyl]-5-[(pyrrolidine-1-yl)sulfonylmethyl]-1H-indol-1-yl}methanol) | F0J055 | 1018676-02-2 | |
| Almotriptan System Suitability (20 mg) (Mixture of Almotriptan Malate and Almotriptan Monomethyl Analog) | F0K134 | N/A | |
| Almotriptan Related Compound B (15 mg) (2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine hemifumarate) | F0M508 | 1246860-65-0 | |
| Almotriptan Related Compound C (15 mg) (N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine) | F0M513 | 334981-12-3 | |
| Almotriptan Related Compound D (15 mg) (1-[({3-[2-(dimethylamino)ethyl]indol-5-yl}methyl)sulfonyl]pyrrolidine N-oxide hydrochloride) | F0M532 | N/A | |
| Aloin (25 mg) | F0M265 | 1415-73-2 | |
| Alpha-Lactalbumin (400 mg) (COLD SHIPMENT REQUIRED) | F0K015 | 9051-29-0 | |
| Alphaprodine Hydrochloride CII (250 mg) | F | 561-78-4 | |
| Alprazolam CIV (200 mg) | I0G195 | H1C133 (30-SEP-2008) | 28981-97-7 |
| Alprazolam Related Compound A (30 mg) (2-(2-acetylhydrazino)-7-chloro-5-phenyl-3H-1,4-benzodiazepine) | F0H056 | 28910-89-6 | |
| Alprostadil (25 mg) | H1F110 | H (30-JUN-2007) | 745-65-3 |
| Altretamine (500 mg) | G0D184 | F (31-MAY-2008) | 645-05-6 |
| Aluminum Sulfate (2 g) (AS) | F0D342 | 17927-65-0 | |
| Dried Aluminum Hydroxide Gel (200 mg) | H0M005 | G0I104 (31-JAN-2014) | 21645-51-2 |
| Amantadine Hydrochloride (200 mg) | I0J377 | H1D207 (31-JAN-2013) | 665-66-7 |
| Amantadine Related Compound A (25 mg) (1-Chloroadamantane) | F014D0 | 935-56-8 | |
| Amantadine Related Compound B (25 mg) (N-(Adamantan-1-yl)acetamide) | F014J0 | 880-52-4 | |
| Amcinonide (200 mg) | I0M261 | H0D346 (30-NOV-2014) | 51022-69-6 |
| Amifostine (150 mg) | F0F075 | 112901-68-5; | |
| 20537-88-6 (anhyd | |||
| Amifostine Disulfide (100 mg) | G0J274 | F0C152 (20-APR-2011) | 112901-68-5 |
| Amifostine Thiol (50 mg) (2-[(3-aminopropyl)amino]ethanethiol, dihydrochloride) | F0F078 | 14653-77-1 | |
| Amikacin Sulfate (100 mg) | F0L324 | 39831-55-5 | |
| Amikacin (300 mg) | R015H0 | K0I162 (30-SEP-2015) | 37517-28-5 |
| Amiloride Hydrochloride (500 mg) | H1G197 | H (30-NOV-2008) | 17440-83-4 |
| Amiloride Related Compound A (30 mg) (Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate) | F1E287 | F0E287 (30-JUN-2016) | 1458-01-1 |
| Aminobenzoate Potassium (200 mg) | F026H2 | F-1 (31-MAR-2016) | 138-84-1 |
| Aminobenzoate Sodium (200 mg) | F | 555-06-6 | |
| Aminobenzoic Acid (200 mg) (p-aminobenzoic acid) | R021P1 | R021P0 (28-FEB-2017) | 150-13-0 |
| 4-Aminobenzoylglutamic Acid (50 mg) | F0M031 | 4271-30-1 | |
| Aminobutanol (500 mg) (1-Butanol, 2-amino-, (+/-)-) | R049T0 | H0G256 (28-FEB-2017) | 96-20-8 |
| Gamma-Aminobutyric Acid (50 mg) | F0L111 | 56-12-2 | |
| Aminocaproic Acid (200 mg) | I0M248 | H0K201 (31-DEC-2015) | 60-32-2 |
| 4-Aminophenol (100 mg) | R009S0 | G0I308 (30-JUN-2015) | 123-30-8 |
| Nitrofurantoin Related Compound A (20 mg) (N-(Aminocarbonyl)-N-[([5-nitro-2-furanyl]-methylene)-amino]-glycine) | H0M496 | G0J181 (28-FEB-2015) | N/A |
| 2-Amino-5-chlorobenzophenone (25 mg) | J0F197 | I (30-SEP-2007) | 719-59-5 |
| Diazepam Related Compound B (25 mg) (3-Amino-6-chloro-1-methyl-4-phenylcarbostyril) | R01830 | K0H414 (31-MAR-2017) | 5220-02-0 |
| Aminoglutethimide (200 mg) | F | 125-84-8 | |
| m-Aminoglutethimide (100 mg) | G | F (31-MAY-2001) | N/A |
| Aminohippuric Acid (200 mg) | G0E338 | F-1 (30-APR-2008) | 61-78-9 |
| Amino Methacrylate Copolymer (1.5 g) | F0G005 | 24938-16-7 | |
| Aminolevulinic Acid Hydrochloride (200 mg) | F013Q0 | 5451-09-2 | |
| Aminolevulinic Acid Related Compound A (25 mg) (3,3'-(Pyrazine-2,5-diyl)dipropionic acid) | F017Y0 | 77479-02-8 | |
| Aminolevulinic Acid Related Compound B (25 mg) (Methyl 5-(1,3-dioxoisoindolin-2-yl)-4-oxopentanoate) | F01800 | 109258-71-1 | |
| 2-[3-Amino-5-(n-methylacetamido)-2,4,6-triiodobenzamido]-2-deoxy-d-glucose (25 mg) | F | N/A | |
| Aminopentamide Sulfate (200 mg) | F0B273 | 60-46-8 | |
| m-Aminophenol (300 mg) | G0J290 | F (31-MAR-2012) | 591-27-5 |
| Aminosalicylic Acid (125 mg) | G1J177 | G0J177 (31-OCT-2015) | 65-49-6 |
| 3-Amino-2,4,6-triiodobenzoic Acid (50 mg) | G | 3119-15-1 | |
| 5-Amino-2,4,6-triiodo-N-methylisophthalamic Acid (50 mg) | F-1 | 2280-89-9 | |
| Amiodarone Hydrochloride (200 mg) | H0M435 | G0G340 (30-JUN-2016) | 19774-82-4 |
| Amiodarone Related Compound D (20 mg) ((2-butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone) | F1J007 | F0J007 (30-JUN-2016) | 1951-26-4 |
| Amiodarone Related Compound E (25 mg) ((2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone) | F1I150 | F0I150 (30-JUN-2016) | 52490-15-0 |
| Amiodarone Related Compound H (20 mg) (2-chloro-N,N-diethylethanamine hydrochloride) | F0I367 | 869-24-9 | |
| Amitraz (200 mg) (COLD SHIPMENT REQUIRED) | H0K161 | G0F313 (30-JUN-2010) | 33089-61-1 |
| Amitraz Related Compound A (40 mg) (N-(2,4-Dimethylphenyl)formamide) | F03850 | 60397-77-5 | |
| Amitraz Related Compound B (40 mg) (N'-(2,4-Dimethylphenyl)-N-methylformimidamide) (COLD SHIPMENT REQUIRED) | F03860 | 33089-74-6 |
